In fact, when resistant genotypes were excluded from the analysis, the percentage difference of patients involved in clusters in 2019/2020/2021 did not reach statistical significance (10.3%/17.2%/44.3% including fluconazole-resistant C. parapsilosis genotypes versus 7.7%/9.2%/11.3% excluding fluconazole-resistant C. parapsilosis genotypes) ( Figure 2 ). 4.
← all excerpts
<i>Candida</i> Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant <i>C. parapsilosis</i>.
1
—
—